The iconic rise of Viagra has consistently remained a example of pharmaceutical success, yet its future within the broader market now presents questions about future gains. Alternative versions are diminishing patent protection , leading to anxieties that investing in companies closely tied to Viagra's once-dominant influence could be a speculative